Interferon beta normalizes suppressor cell function in dysimmune neuropathies

Journal of Neuroimmunology

Volumn 82, Issue 1, 1998, Pages 1-4

  De Luca, Giovanna ^a   Lugaresi, Alessandra ^a   Iarlori, Carla ^a   Marzoli, Fabio ^a   Uncini, Antonino ^a   Gambi, Domenico ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Myelin associated glycoprotein; Recombinant human IFN 1a; Sulfated glucuronyl paragloboside; Suppressor cell function

Indexed keywords

BETA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CHRONIC INFLAMMATION; CLINICAL ARTICLE; DEMYELINATING NEUROPATHY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOMODULATION; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SUPPRESSOR CELL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; CHILD; DEMYELINATING DISEASES; FEMALE; GLOBOSIDES; HUMANS; IMMUNOGLOBULIN M; INTERFERON-BETA; MALE; MIDDLE AGED; MYELIN-ASSOCIATED GLYCOPROTEIN; PARAPROTEINEMIAS; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYNEUROPATHIES; RECOMBINANT PROTEINS;

EID: 0032005112     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00170-7     Document Type: Article

References (18)

1. Ad hoc Subcommittee of the American Academy of Neurology AIDS Task Force Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 41:1991;617-618.
2. Antel J.P., Bania M., Noronha A. Defective suppressor cell function mediated by T8+ cell lines from patients with progressive multiple sclerosis. J. Immunol. 137:1986;3436-3439.
3. Choudhary P.P., Thompson N., Hughes R.A. Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy. J. Neurol. 242:1995;252-253. Letter.
4. Dyck, P.J., Prineas, J., Pollard, J., 1993. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck, P.J., Thomas, P.K., Griffin, J.W., Low, P.A., Poduslo, J.F. (Eds.), Peripheral Neuropathy, 3rd ed. Saunders, Philadelphia, pp. 1498-1517.
5. Hartung, H.P., Stoll, G., Toyka, K.V., 1993. Immune reactions in the peripheral nervous system. In: Dyck, P.J., Thomas, P.K., Griffin, J.W., Low, P.A., Poduslo, J.F. (Eds.), Peripheral Neuropathy, 3rd ed. Saunders, Philadelphia, pp. 418-444.
6. Harvey G.K., Gold R., Hartung H.P., Toyka K.V. Nonneural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy. Brain. 118:1995;1263-1272.
7. Latov N., Hays A.P., Sherman W.H. Peripheral neuropathy and anti-MAG antibodies. CRC Crit. Rev. Neurobiol. 3:1988;301-332.
8. Noronha A., Toscas A., Jensen M.A. Interferon augments suppressor cells function in multiple sclerosis. Ann. Neurol. 27:1990;207-210.
9. Noronha A., Toscas A., Arnason B.G.W., Jensen M. Interferon beta augments in vivo suppressor function in MS. Neurology. 44(suppl 2):1994;A212.
10. Noronha A., Toscas A., Jensen M.A. Interferon-β decreases T cell activation and interferon-γ production in multiple sclerosis. J. Neuroimmunol. 46:1993;145-154.
11. 1 affect monokine secretion: relevance to monocyte activation in multiple sclerosis. Cell. Immunol. 157:1994;428-438.
12. Porrini A.M., Gambi D., Reder A.T. Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J. Neuroimmunol. 61:1995;27-34.
13. Rudick R.A., Ransohoff M.R., Peppler R., VanderBrug Medendorp S., Lehmann P., Alam J. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann. Neurol. 40:1996;618-627.
14. Simmons Z., Albers J., Bromberg M.B., Feldman E.L. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain. 118:1995;359-368.
15. Tatum A.H. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann. Neurol. 33:1993;502-506.
16. Toyka K.V., Hartung H.P. Chronic inflammatory polyneuritis and related neuropathies. Curr. Opin. Neurol. 9:1996;240-250.
17. Van den Berg L., Hays A.P., Nobile-Orazio E., Kinsella J., Manfredini E., Corbo M., Rosoklija G., Younger D.S., Lovelace R.E., Trojaborg W., Lange D.E., Goldstein S., Delfiner J.S., Sadiq S.A., Sherman V.H., Latov N. Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve. 19:1996;637-643.
18. van der Meché F.G.A., van Doorn P.A. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann. Neurol. 37 (Suppl. 1):1995;S14-S31.